157 related articles for article (PubMed ID: 11463136)
1. Perospirone.
Onrust SV; McClellan K
CNS Drugs; 2001; 15(4):329-37; discussion 338. PubMed ID: 11463136
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacological characteristics of perospirone hydrochloride, a novel antipsychotic agent].
Ohno Y
Nihon Yakurigaku Zasshi; 2000 Oct; 116(4):225-31. PubMed ID: 11084919
[TBL] [Abstract][Full Text] [Related]
3. Perospirone in the treatment of patients with delirium.
Takeuchi T; Furuta K; Hirasawa T; Masaki H; Yukizane T; Atsuta H; Nishikawa T
Psychiatry Clin Neurosci; 2007 Feb; 61(1):67-70. PubMed ID: 17239041
[TBL] [Abstract][Full Text] [Related]
4. Randomized clinical comparison of perospirone and risperidone in patients with schizophrenia: Kansai Psychiatric Multicenter Study.
Okugawa G; Kato M; Wakeno M; Koh J; Morikawa M; Matsumoto N; Shinosaki K; Yoneda H; Kishimoto T; Kinoshita T
Psychiatry Clin Neurosci; 2009 Jun; 63(3):322-8. PubMed ID: 19566763
[TBL] [Abstract][Full Text] [Related]
5. [Perospirone therapy in elderly patients with schizophrenia].
Masui T; Honma H; Kondo C; Osawa T; Iwasaki S; Matsubara S
Seishin Shinkeigaku Zasshi; 2003; 105(10):1247-53. PubMed ID: 14679781
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and tolerability of perospirone in schizophrenia: a systematic review and meta-analysis of randomized controlled trials.
Kishi T; Iwata N
CNS Drugs; 2013 Sep; 27(9):731-41. PubMed ID: 23812802
[TBL] [Abstract][Full Text] [Related]
7. Effective treatment of coprophagia in a patient with schizophrenia with the novel atypical antipsychotic drug perospirone.
Harada KI; Yamamoto K; Saito T
Pharmacopsychiatry; 2006 May; 39(3):113. PubMed ID: 16721701
[TBL] [Abstract][Full Text] [Related]
8. Perospirone in the treatment of schizophrenia: effect on verbal memory organization.
Araki T; Yamasue H; Sumiyoshi T; Kuwabara H; Suga M; Iwanami A; Kato N; Kasai K
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):204-8. PubMed ID: 16300872
[TBL] [Abstract][Full Text] [Related]
9. Perospirone. SM 9018.
Drugs R D; 1999 Aug; 2(2):142-3. PubMed ID: 10820662
[No Abstract] [Full Text] [Related]
10. Long-term perospirone treatment with a single dose at bedtime in schizophrenia: relevant to intermittent dopamine D2 receptor antagonism.
Kusumi I; Masui T; Koyama T
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):520-2. PubMed ID: 18006133
[TBL] [Abstract][Full Text] [Related]
11. Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder.
Swainston Harrison T; Perry CM
Drugs; 2004; 64(15):1715-36. PubMed ID: 15257633
[TBL] [Abstract][Full Text] [Related]
12. Antagonist and partial agonist at the dopamine D2 receptors in drug-naïve and non-drug-naïve schizophrenia: a randomized, controlled trial.
Takekita Y; Fabbri C; Kato M; Nonen S; Sakai S; Sunada N; Koshikawa Y; Wakeno M; Okugawa G; Kinoshita T; Serretti A
Eur Arch Psychiatry Clin Neurosci; 2015 Oct; 265(7):579-88. PubMed ID: 26016467
[TBL] [Abstract][Full Text] [Related]
13. The effect of perospirone on auditory P300 in schizophrenia: a preliminary study.
Araki T; Kasai K; Rogers MA; Kato N; Iwanami A
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1083-90. PubMed ID: 16723179
[TBL] [Abstract][Full Text] [Related]
14. A 12-week randomized, open-label study of perospirone versus aripiprazole in the treatment of Japanese schizophrenia patients.
Takekita Y; Kato M; Wakeno M; Sakai S; Suwa A; Nishida K; Okugawa G; Kinoshita T
Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jan; 40():110-4. PubMed ID: 23022672
[TBL] [Abstract][Full Text] [Related]
15. Two cases of perospirone-induced mania in schizophrenia.
Yokoshima T; Takei N; Tani K; Kawai M; Minabe Y; Mori N
J Clin Psychiatry; 2004 Jan; 65(1):135. PubMed ID: 14974495
[No Abstract] [Full Text] [Related]
16. Perospirone. SM 9018.
Drugs R D; 1999 Jul; 2(1):60-2. PubMed ID: 10610286
[No Abstract] [Full Text] [Related]
17. Impact of a switch from typical to atypical antipsychotic drugs on quality of life and gonadal hormones in male patients with schizophrenia.
Kaneda Y; Kawamura I; Fujii A; Ohmori T
Neuro Endocrinol Lett; 2004; 25(1-2):135-40. PubMed ID: 15159697
[TBL] [Abstract][Full Text] [Related]
18. Perospirone (Sumitomo Pharmaceuticals).
de Paulis T
Curr Opin Investig Drugs; 2002 Jan; 3(1):121-9. PubMed ID: 12054062
[TBL] [Abstract][Full Text] [Related]
19. Use of perospirone for obesity and diabetes mellitus in patients with schizophrenia: three case reports.
Nishida M; Nakamura M
Int Clin Psychopharmacol; 2004 Jan; 19(1):41-3. PubMed ID: 15101570
[TBL] [Abstract][Full Text] [Related]
20. Anxiolytic-like effects of perospirone, a novel serotonin-2 and dopamine-2 antagonist (SDA)-type antipsychotic agent.
Sakamoto H; Matsumoto K; Ohno Y; Nakamura M
Pharmacol Biochem Behav; 1998 Aug; 60(4):873-8. PubMed ID: 9700971
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
